HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3'- hydroxy- 5,7- dimethoxy- 4- O- 2'- cycloflavan

inhibits beta-amyloid aggregation; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        3'-hydroxy-5,7-dimethoxy-4-O-2'-cycloflavan: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        3'-hydroxy-5,7-dimethoxy-4-O-2'-cycloflavan: 1

Experts

1.	Chen, Huiyu: 1 article (01/2022)
2.	Lu, Xiuxiang: 1 article (01/2022)
3.	Tan, Haibo: 1 article (01/2022)
4.	Zhang, Wenge: 1 article (01/2022)
5.	Zheng, Anquan: 1 article (01/2022)
6.	Zhou, Tingting: 1 article (01/2022)

Related Diseases

1.	Dehydration (Water Stress) 01/01/2022 - "A two-step protecting-group-free protocol for the synthesis of 3'-hydroxy-5,7-dimethoxy-4-O-2'-cycloflavan (1) and concise total synthesis of 4'-hydroxy-5,7-dimethoxy-4-O-2'-cycloflavan (8) enabled by a PTSA triggered bioinspired olefin isomerization/hemiacetalization/dehydration/[3 + 3]-type cycloaddition cascade reaction are reported. "

Related Drugs and Biologics

1.	Alkenes (Olefins)
2.	1,3,6,8-pyrene tetrasulfonate (PTSA)